Pearson returns as Valeant's chief executive

29 February 2016 - Deborah Wilkes

Archived

Valeant Pharmaceuticals International said Michael Pearson had returned as chief executive officer following his recovery from a severe case of pneumonia.

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: